These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
622 related items for PubMed ID: 22398098
1. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA. J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098 [Abstract] [Full Text] [Related]
2. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM. J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [Abstract] [Full Text] [Related]
4. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease. Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK. Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923 [Abstract] [Full Text] [Related]
11. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Jharap B, de Boer NK, Stokkers P, Hommes DW, Oldenburg B, Dijkstra G, van der Woude CJ, de Jong DJ, Mulder CJ, van Elburg RM, van Bodegraven AA, Dutch Initiative on Crohn and Colitis. Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097 [Abstract] [Full Text] [Related]
18. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases. Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT. J Clin Gastroenterol; 2018 Jul; 52(6):537-544. PubMed ID: 28723860 [Abstract] [Full Text] [Related]
19. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients. González-Lama Y, Bermejo F, López-Sanromán A, García-Sánchez V, Esteve M, Cabriada JL, McNicholl AG, Pajares R, Casellas F, Merino O, Carpio D, Vera MI, Muñoz C, Calvo M, Benito LM, Bujanda L, García-Fernández FJ, Ricart E, Ginard D, Velasco M, Carneros JA, Manceñido N, Calvo M, Algaba A, Froilan C, Cara C, Maté J, Abreu L, Gisbert JP, "Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)". Aliment Pharmacol Ther; 2011 Sep; 34(5):544-54. PubMed ID: 21722149 [Abstract] [Full Text] [Related]
20. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Dilger K, Schaeffeler E, Lukas M, Strauch U, Herfarth H, Müller R, Schwab M. Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]